A fund’s 4.59M pre-funded warrants face an exercise cap at NewAmsterdam Pharma (NAMS).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. reported a 9.99% beneficial ownership stake in NewAmsterdam Pharma Co N.V. (NAMS) as of September 30, 2026. The filing highlights that the fund holds ordinary shares, ordinary share warrants, and pre-funded warrants, with an exercise cap preventing ownership from exceeding 9.99% of outstanding shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.